NeCEN and the development of the Johnson & Johnson Covid-19 vaccine

The Phase 3 clinical trial results of the Covid-19 vaccine of Johnson & Johnson are expected this month. NeCEN played a role in the underlying research that led to the development of this vaccine. The scientific findings have now been published in Nature Communications.


The full article is now available on the Nature Communications website. More information on the development of the vaccine and an interview with our Head of facility can be found here.